v3.25.4
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Consolidated Statements of Comprehensive Loss [Abstract]    
License and collaborations revenue $ 14,196 $ 10,992
Operating expenses:    
Research and development 30,812 26,851
General and administrative 21,983 18,215
Acquired in-process research and development 0 28,000
Total operating expenses 52,795 73,066
Loss from operations (38,599) (62,074)
Fair value change in warrant and other derivative liabilities (11,515) 72
Financing costs (Note 7) (1,337) 0
Interest expense (129) 0
Other income, net 1,989 4,470
Loss before income taxes (49,591) (57,532)
Provision for income taxes 0 0
Net loss (49,591) (57,532)
Other comprehensive loss, net of tax 0 0
Comprehensive loss $ (49,591) $ (57,532)
Net loss per share (Note 11):    
Basic (in dollars per share) $ (0.8) $ (2.15)
Diluted (in dollars per share) $ (0.8) $ (2.15)
Number of shares used in per share calculations:    
Basic (in shares) 62,221,901 26,715,526
Diluted (in shares) 62,221,901 26,715,526

Source